Logo image of SBS.DE

STRATEC SE (SBS.DE) Stock Fundamental Analysis

Europe - FRA:SBS - DE000STRA555 - Common Stock

29.6 EUR
-0.25 (-0.84%)
Last: 9/25/2025, 10:25:59 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SBS. SBS was compared to 58 industry peers in the Health Care Equipment & Supplies industry. SBS has an average financial health and profitability rating. SBS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

SBS had positive earnings in the past year.
SBS had a positive operating cash flow in the past year.
Each year in the past 5 years SBS has been profitable.
In the past 5 years SBS always reported a positive cash flow from operatings.
SBS.DE Yearly Net Income VS EBIT VS OCF VS FCFSBS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

The Return On Assets of SBS (3.79%) is comparable to the rest of the industry.
SBS has a Return On Equity of 6.77%. This is comparable to the rest of the industry: SBS outperforms 56.90% of its industry peers.
The Return On Invested Capital of SBS (5.71%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for SBS is in line with the industry average of 8.65%.
Industry RankSector Rank
ROA 3.79%
ROE 6.77%
ROIC 5.71%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
SBS.DE Yearly ROA, ROE, ROICSBS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SBS's Profit Margin of 6.22% is in line compared to the rest of the industry. SBS outperforms 51.72% of its industry peers.
In the last couple of years the Profit Margin of SBS has declined.
SBS's Operating Margin of 10.94% is in line compared to the rest of the industry. SBS outperforms 55.17% of its industry peers.
In the last couple of years the Operating Margin of SBS has grown nicely.
With a Gross Margin value of 29.65%, SBS is not doing good in the industry: 84.48% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SBS has grown nicely.
Industry RankSector Rank
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
SBS.DE Yearly Profit, Operating, Gross MarginsSBS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

SBS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SBS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SBS has more shares outstanding
SBS has a better debt/assets ratio than last year.
SBS.DE Yearly Shares OutstandingSBS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SBS.DE Yearly Total Debt VS Total AssetsSBS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

SBS has an Altman-Z score of 3.03. This indicates that SBS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.03, SBS is doing good in the industry, outperforming 63.79% of the companies in the same industry.
SBS has a debt to FCF ratio of 18.15. This is a negative value and a sign of low solvency as SBS would need 18.15 years to pay back of all of its debts.
SBS's Debt to FCF ratio of 18.15 is in line compared to the rest of the industry. SBS outperforms 44.83% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that SBS is not too dependend on debt financing.
SBS has a Debt to Equity ratio of 0.40. This is comparable to the rest of the industry: SBS outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 18.15
Altman-Z 3.03
ROIC/WACC0.9
WACC6.35%
SBS.DE Yearly LT Debt VS Equity VS FCFSBS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

SBS has a Current Ratio of 3.02. This indicates that SBS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.02, SBS belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
SBS has a Quick Ratio of 1.15. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
SBS has a Quick ratio (1.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 1.15
SBS.DE Yearly Current Assets VS Current LiabilitesSBS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.26% over the past year.
The Earnings Per Share has been growing slightly by 2.20% on average over the past years.
The Revenue has decreased by -4.73% in the past year.
Measured over the past years, SBS shows a small growth in Revenue. The Revenue has been growing by 3.76% on average per year.
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%-25.09%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%73.87%

3.2 Future

Based on estimates for the next years, SBS will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.67% on average per year.
SBS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.79% yearly.
EPS Next Y1.06%
EPS Next 2Y14.72%
EPS Next 3Y15.6%
EPS Next 5Y16.67%
Revenue Next Year4.14%
Revenue Next 2Y5.34%
Revenue Next 3Y5.82%
Revenue Next 5Y5.79%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBS.DE Yearly Revenue VS EstimatesSBS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M
SBS.DE Yearly EPS VS EstimatesSBS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.42, which indicates a rather expensive current valuation of SBS.
Based on the Price/Earnings ratio, SBS is valued a bit cheaper than the industry average as 75.86% of the companies are valued more expensively.
SBS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.22, which indicates a correct valuation of SBS.
SBS's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBS is cheaper than 86.21% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.80. SBS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.42
Fwd PE 14.22
SBS.DE Price Earnings VS Forward Price EarningsSBS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SBS indicates a rather cheap valuation: SBS is cheaper than 84.48% of the companies listed in the same industry.
SBS's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 50.75
EV/EBITDA 9.91
SBS.DE Per share dataSBS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SBS's earnings are expected to grow with 15.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)21.09
PEG (5Y)10.22
EPS Next 2Y14.72%
EPS Next 3Y15.6%

4

5. Dividend

5.1 Amount

SBS has a Yearly Dividend Yield of 2.11%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.14, SBS pays a better dividend. On top of this SBS pays more dividend than 84.48% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, SBS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

The dividend of SBS decreases each year by -7.63%.
Dividend Growth(5Y)-7.63%
Div Incr Years0
Div Non Decr Years5
SBS.DE Yearly Dividends per shareSBS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

SBS pays out 45.53% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP45.53%
EPS Next 2Y14.72%
EPS Next 3Y15.6%
SBS.DE Yearly Income VS Free CF VS DividendSBS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
SBS.DE Dividend Payout.SBS.DE Dividend Payout, showing the Payout Ratio.SBS.DE Dividend Payout.PayoutRetained Earnings

STRATEC SE

FRA:SBS (9/25/2025, 10:25:59 AM)

29.6

-0.25 (-0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-19 2025-08-19
Earnings (Next)11-07 2025-11-07
Inst Owners37.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap359.94M
Analysts80
Price Target37.5 (26.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Yearly Dividend0.55
Dividend Growth(5Y)-7.63%
DP45.53%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.23%
PT rev (3m)-6.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE 22.42
Fwd PE 14.22
P/S 1.4
P/FCF 50.75
P/OCF 14.08
P/B 1.52
P/tB 2.9
EV/EBITDA 9.91
EPS(TTM)1.32
EY4.46%
EPS(NY)2.08
Fwd EY7.03%
FCF(TTM)0.58
FCFY1.97%
OCF(TTM)2.1
OCFY7.1%
SpS21.19
BVpS19.47
TBVpS10.19
PEG (NY)21.09
PEG (5Y)10.22
Profitability
Industry RankSector Rank
ROA 3.79%
ROE 6.77%
ROCE 7.93%
ROIC 5.71%
ROICexc 6.07%
ROICexgc 9.15%
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
FCFM 2.75%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
ROICexc(3y)7.69%
ROICexc(5y)10.12%
ROICexgc(3y)11.48%
ROICexgc(5y)16.01%
ROCE(3y)9.61%
ROCE(5y)11.28%
ROICexcg growth 3Y-26.1%
ROICexcg growth 5Y2.82%
ROICexc growth 3Y-25.31%
ROICexc growth 5Y3.93%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 18.15
Debt/EBITDA 2.02
Cap/Depr 96.38%
Cap/Sales 7.17%
Interest Coverage 5.24
Cash Conversion 53.99%
Profit Quality 44.27%
Current Ratio 3.02
Quick Ratio 1.15
Altman-Z 3.03
F-Score7
WACC6.35%
ROIC/WACC0.9
Cap/Depr(3y)101.4%
Cap/Depr(5y)105.66%
Cap/Sales(3y)6.8%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%-25.09%
EPS Next Y1.06%
EPS Next 2Y14.72%
EPS Next 3Y15.6%
EPS Next 5Y16.67%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%73.87%
Revenue Next Year4.14%
Revenue Next 2Y5.34%
Revenue Next 3Y5.82%
Revenue Next 5Y5.79%
EBIT growth 1Y-3.3%
EBIT growth 3Y-17.64%
EBIT growth 5Y9.13%
EBIT Next Year90.13%
EBIT Next 3Y33.27%
EBIT Next 5Y16.72%
FCF growth 1Y123.24%
FCF growth 3Y-10.96%
FCF growth 5YN/A
OCF growth 1Y342.46%
OCF growth 3Y-8.44%
OCF growth 5Y18.03%